What are the major opportunities in the Non-injectable Insulin market? What are the strategies for the Non-injectable Insulin market?

For detailed insights on the major opportunities and strategies in the Non-injectable Insulin market, Read More

How does the Non-injectable Insulin market relate to the overall economy and other similar markets?

For detailed insights on Non-injectable Insulin's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Non-injectable Insulin market growth? SWOT analysis of the Non-injectable Insulin market.

For detailed insights on the key dynamics influencing the Non-injectable Insulin market growth and SWOT analysis of the Non-injectable Insulin industry, Read More

Non-injectable Insulin Market Global Report 2026 Market Report Infographic Image

Item added to cart!

Published : February 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Non-injectable Insulin Market Report 2026

Name: Non-injectable Insulin Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Insulin Type (Oral Insulin, Inhaled Insulin, Nasal Insulin, Buccal Or Sublingual Insulin, Transdermal Insulin), By Product (Pills, Sprays, Other Products), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, Drug Stores) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Non-injectable Insulin Market Overview

• Non-injectable Insulin market size has reached to $2.14 billion in 2025

• Expected to grow to $3.41 billion in 2030 at a compound annual growth rate (CAGR) of 9.8%

• Growth Driver: Expanding Non-Injectable Insulin Market Fueled by Escalating Obesity and Diabetes Epidemics

• Market Trend: Innovative Advancements In Non-Injectable Insulin Delivery

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Non-injectable Insulin Market?

Non-injectable insulin is a type of insulin that can be administered into the body without the need for injection. These non-injectable forms of insulin aim to offer alternatives to traditional injections, making diabetes management more accessible and potentially improving the overall quality of life for individuals with diabetes.

The main types of non-injectable insulin are synthetic insulin and semi-synthetic insulin. Synthetic insulin refers to artificially produced insulin that is created through biotechnological methods rather than being extracted from animal sources. These can be found in various product types, such as pills, sprays, and other products, and they are distributed through hospital pharmacies, online pharmacies, and drug stores.

Non-injectable Insulin Market Global Report 2026 Market Report bar graph

What Is The Non-injectable Insulin Market Size and Share 2026?

The non-injectable insulin market size has grown strongly in recent years. It will grow from $2.14 billion in 2025 to $2.35 billion in 2026 at a compound annual growth rate (CAGR) of 9.9%. The growth in the historic period can be attributed to increasing prevalence of diabetes, rising patient preference for non-injective therapies, advancements in insulin formulation, government initiatives promoting diabetes care, growing awareness about diabetes complications.

What Is The Non-injectable Insulin Market Growth Forecast?

The non-injectable insulin market size is expected to see strong growth in the next few years. It will grow to $3.41 billion in 2030 at a compound annual growth rate (CAGR) of 9.8%. The growth in the forecast period can be attributed to technological advancements in oral and inhalable insulin, integration of digital health solutions, rising geriatric population, expansion of healthcare infrastructure in emerging markets, personalized medicine approaches for diabetes. Major trends in the forecast period include oral insulin delivery systems, pulmonary insulin inhalers, patient-centric diabetes management, non-invasive monitoring & dosing, formulation innovations for improved bioavailability.

Book your 30 minutes free consultation with our research experts

Global Non-injectable Insulin Market Segmentation

1) By Insulin Type: Oral Insulin, Inhaled Insulin, Nasal Insulin, Buccal Or Sublingual Insulin, Transdermal Insulin

2) By Product: Pills, Sprays, Other Products

3) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Drug Stores

Subsegments:

1) By Oral Insulin: Oral Insulin Tablets, Oral Insulin Capsules, Enteric-Coated Oral Insulin, Nanoparticle-Based Oral Insulin

2) By Inhaled Insulin: Dry Powder Inhaled Insulin, Aerosolized Insulin, Pulmonary Insulin Delivery Systems

3) By Nasal Insulin: Nasal Spray Insulin, Nasal Gel Insulin, Nasal Powder Insulin

4) By Buccal Or Sublingual Insulin: Buccal Spray Insulin, Sublingual Insulin Films, Oral Mucosal Insulin Drops

5) By Transdermal Insulin: Insulin Patches, Microneedle-Free Transdermal Systems, Iontophoresis-Based Insulin Delivery

What Is The Driver Of The Non-injectable Insulin Market?

The rising obesity and diabetes issues are expected to propel the growth of the non-injectable insulin market going forward. Obesity is a condition characterized by excessive accumulation of body fat, usually resulting from an imbalance between energy intake (calories consumed) and energy expenditure, while diabetes mellitus, often referred to simply as diabetes, is a group of metabolic disorders characterized by high blood sugar levels over a prolonged period. Non-injectable insulin is used to treat diabetes and obesity, with the potential to improve management by addressing barriers to insulin therapy, offering potential weight management benefits, and providing more convenient treatment options. For instance, in June 2023, according to the Institute for Health Metrics and Evaluation, a US-based public health research institute, reported that over half a billion people globally were living with diabetes. This number is expected to more than double, reaching 1.3 billion people by 2050. Therefore, rising obesity and diabetes issues are driving the growth of the non-injectable insulin industry.

Key Players In The Global Non-injectable Insulin Market

Major companies operating in the non-injectable insulin market are Novo Nordisk A/S, Eli Lilly and Company, Sanofi S.A., Pfizer Inc., Novartis AG, Merck & Co. Inc., AstraZeneca, Takeda Pharmaceutical, Abbott Laboratories, MannKind Corporation, Biocon Limited, Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Limited, Cipla Limited, Lupin Pharmaceuticals, Glenmark Pharmaceuticals, Torrent Pharmaceuticals, Wockhardt Limited, Teva Pharmaceutical Industries Ltd., F. Hoffmann-La Roche Ltd.

Global Non-injectable Insulin Market Trends and Insights

Major companies operating in the non-injectable insulin market are focusing on innovative advancements in drug delivery technologies, such as needle-free oral insulin spray, to improve the lives of people who manage their diabetes with multiple insulin injections. A needle-free insulin spray is a painless and needle-free alternative for regulating blood glucose, offering a convenient option as the doses can be sprayed directly into the mouth. For instance, in November 2023, NiedlFree Technologies, an India-based technology platform, introduced Ozulin, an oral insulin spray. This oral insulin spray is intended to provide a more user-friendly solution for individuals with diabetes, particularly those who may find traditional injectable insulin methods challenging. If approved, Ozulin has the potential to be a game-changer for diabetics, offering a more convenient and pain-free alternative to insulin injections.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Non-injectable Insulin Market?

In September 2023, Abbott Laboratories, a US-based medical device company, acquired Bigfoot Biomedical Inc. for an undisclosed amount. This acquisition combines Abbott's expertise in continuous glucose monitoring with Bigfoot's smart insulin management systems and strengthens Abbott's position as a leader in comprehensive diabetes care, aligning with the commitment to advancing connected solutions for precise diabetes management. Bigfoot Biomedical Inc., a US-based medical technology company, offers intelligent insulin administration systems for diabetes care.

Regional Insights

North America was the largest region in the non-injectable insulin market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Non-injectable Insulin Market?

The non-injectable insulin market consists of sales of oral insulin, inhaled insulin, nasal insulin, carrier agents, and stabilizers. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Non-injectable Insulin Market Report 2026?

The non-injectable insulin market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the non-injectable insulin industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Non-injectable Insulin Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$2.35 billion
Revenue Forecast In 2035	$3.41 billion
Growth Rate	CAGR of 9.9% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Insulin Type, Product, Distribution Channel
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Novo Nordisk A/S, Eli Lilly and Company, Sanofi S.A., Pfizer Inc., Novartis AG, Merck & Co. Inc., AstraZeneca, Takeda Pharmaceutical, Abbott Laboratories, MannKind Corporation, Biocon Limited, Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Non-injectable Insulin Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Non-injectable Insulin Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Non-injectable Insulin Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Non-injectable Insulin Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.1.4 Artificial Intelligence & Autonomous Intelligence

4.1.5 Industry 4.0 & Intelligent Manufacturing

4.2. Major Trends

4.2.1 Oral Insulin Delivery Systems

4.2.2 Pulmonary Insulin Inhalers

4.2.3 Patient-Centric Diabetes Management

4.2.4 Non-Invasive Monitoring & Dosing

4.2.5 Formulation Innovations For Improved Bioavailability

5. Non-injectable Insulin Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Clinics

5.3 Diabetes Care Centers

5.4 Pharmacies

5.5 Homecare Patients

6. Non-injectable Insulin Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Non-injectable Insulin Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Non-injectable Insulin PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Non-injectable Insulin Market Size, Comparisons And Growth Rate Analysis

7.3. Global Non-injectable Insulin Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Non-injectable Insulin Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Non-injectable Insulin Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Non-injectable Insulin Market Segmentation

9.1. Global Non-injectable Insulin Market, Segmentation By Insulin Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oral Insulin, Inhaled Insulin, Nasal Insulin, Buccal Or Sublingual Insulin, Transdermal Insulin

9.2. Global Non-injectable Insulin Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Pills, Sprays, Other Products

9.3. Global Non-injectable Insulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital Pharmacies, Online Pharmacies, Drug Stores

9.4. Global Non-injectable Insulin Market, Sub-Segmentation Of Oral Insulin, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oral Insulin Tablets, Oral Insulin Capsules, Enteric-Coated Oral Insulin, Nanoparticle-Based Oral Insulin

9.5. Global Non-injectable Insulin Market, Sub-Segmentation Of Inhaled Insulin, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Dry Powder Inhaled Insulin, Aerosolized Insulin, Pulmonary Insulin Delivery Systems

9.6. Global Non-injectable Insulin Market, Sub-Segmentation Of Nasal Insulin, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Nasal Spray Insulin, Nasal Gel Insulin, Nasal Powder Insulin

9.7. Global Non-injectable Insulin Market, Sub-Segmentation Of Buccal Or Sublingual Insulin, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Buccal Spray Insulin, Sublingual Insulin Films, Oral Mucosal Insulin Drops

9.8. Global Non-injectable Insulin Market, Sub-Segmentation Of Transdermal Insulin, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Insulin Patches, Microneedle-Free Transdermal Systems, Iontophoresis-Based Insulin Delivery

10. Non-injectable Insulin Market Regional And Country Analysis

10.1. Global Non-injectable Insulin Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Non-injectable Insulin Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Non-injectable Insulin Market

11.1. Asia-Pacific Non-injectable Insulin Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Non-injectable Insulin Market, Segmentation By Insulin Type, Segmentation By Product, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Non-injectable Insulin Market

12.1. China Non-injectable Insulin Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Non-injectable Insulin Market, Segmentation By Insulin Type, Segmentation By Product, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Non-injectable Insulin Market

13.1. India Non-injectable Insulin Market, Segmentation By Insulin Type, Segmentation By Product, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Non-injectable Insulin Market

14.1. Japan Non-injectable Insulin Market Overview

14.2. Japan Non-injectable Insulin Market, Segmentation By Insulin Type, Segmentation By Product, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Non-injectable Insulin Market

15.1. Australia Non-injectable Insulin Market, Segmentation By Insulin Type, Segmentation By Product, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Non-injectable Insulin Market

16.1. Indonesia Non-injectable Insulin Market, Segmentation By Insulin Type, Segmentation By Product, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Non-injectable Insulin Market

17.1. South Korea Non-injectable Insulin Market Overview

17.2. South Korea Non-injectable Insulin Market, Segmentation By Insulin Type, Segmentation By Product, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Non-injectable Insulin Market

18.1. Taiwan Non-injectable Insulin Market Overview

18.2. Taiwan Non-injectable Insulin Market, Segmentation By Insulin Type, Segmentation By Product, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Non-injectable Insulin Market

19.1. South East Asia Non-injectable Insulin Market Overview

19.2. South East Asia Non-injectable Insulin Market, Segmentation By Insulin Type, Segmentation By Product, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Non-injectable Insulin Market

20.1. Western Europe Non-injectable Insulin Market Overview

20.2. Western Europe Non-injectable Insulin Market, Segmentation By Insulin Type, Segmentation By Product, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Non-injectable Insulin Market

21.1. UK Non-injectable Insulin Market, Segmentation By Insulin Type, Segmentation By Product, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Non-injectable Insulin Market

22.1. Germany Non-injectable Insulin Market, Segmentation By Insulin Type, Segmentation By Product, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Non-injectable Insulin Market

23.1. France Non-injectable Insulin Market, Segmentation By Insulin Type, Segmentation By Product, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Non-injectable Insulin Market

24.1. Italy Non-injectable Insulin Market, Segmentation By Insulin Type, Segmentation By Product, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Non-injectable Insulin Market

25.1. Spain Non-injectable Insulin Market, Segmentation By Insulin Type, Segmentation By Product, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Non-injectable Insulin Market

26.1. Eastern Europe Non-injectable Insulin Market Overview

26.2. Eastern Europe Non-injectable Insulin Market, Segmentation By Insulin Type, Segmentation By Product, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Non-injectable Insulin Market

27.1. Russia Non-injectable Insulin Market, Segmentation By Insulin Type, Segmentation By Product, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Non-injectable Insulin Market

28.1. North America Non-injectable Insulin Market Overview

28.2. North America Non-injectable Insulin Market, Segmentation By Insulin Type, Segmentation By Product, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Non-injectable Insulin Market

29.1. USA Non-injectable Insulin Market Overview

29.2. USA Non-injectable Insulin Market, Segmentation By Insulin Type, Segmentation By Product, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Non-injectable Insulin Market

30.1. Canada Non-injectable Insulin Market Overview

30.2. Canada Non-injectable Insulin Market, Segmentation By Insulin Type, Segmentation By Product, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Non-injectable Insulin Market

31.1. South America Non-injectable Insulin Market Overview

31.2. South America Non-injectable Insulin Market, Segmentation By Insulin Type, Segmentation By Product, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Non-injectable Insulin Market

32.1. Brazil Non-injectable Insulin Market, Segmentation By Insulin Type, Segmentation By Product, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Non-injectable Insulin Market

33.1. Middle East Non-injectable Insulin Market Overview

33.2. Middle East Non-injectable Insulin Market, Segmentation By Insulin Type, Segmentation By Product, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Non-injectable Insulin Market

34.1. Africa Non-injectable Insulin Market Overview

34.2. Africa Non-injectable Insulin Market, Segmentation By Insulin Type, Segmentation By Product, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Non-injectable Insulin Market Regulatory and Investment Landscape

36. Non-injectable Insulin Market Competitive Landscape And Company Profiles

36.1. Non-injectable Insulin Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Non-injectable Insulin Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Non-injectable Insulin Market Company Profiles

36.3.1. Novo Nordisk A/S Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

37. Non-injectable Insulin Market Other Major And Innovative Companies

Merck & Co. Inc., AstraZeneca, Takeda Pharmaceutical, Abbott Laboratories, MannKind Corporation, Biocon Limited, Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Limited, Cipla Limited, Lupin Pharmaceuticals, Glenmark Pharmaceuticals, Torrent Pharmaceuticals, Wockhardt Limited, Teva Pharmaceutical Industries Ltd., F. Hoffmann-La Roche Ltd.

38. Global Non-injectable Insulin Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Non-injectable Insulin Market

40. Non-injectable Insulin Market High Potential Countries, Segments and Strategies

40.1 Non-injectable Insulin Market In 2030 - Countries Offering Most New Opportunities

40.2 Non-injectable Insulin Market In 2030 - Segments Offering Most New Opportunities

40.3 Non-injectable Insulin Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Non-injectable Insulin Market, Overview Of Key Products - Product Examples

Table 2: Global Non-injectable Insulin Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Non-injectable Insulin Market, Supply Chain Analysis

Table 4: Global Non-injectable Insulin Market, Major Raw Material Providers

Table 5: Global Non-injectable Insulin Market, Major Resource Providers

Table 6: Global Non-injectable Insulin Market, Major Manufacturers (Suppliers)

Table 7: Global Non-injectable Insulin Market, Major Distributors And Channel Partners

Table 8: Global Non-injectable Insulin Market, Key Technologies & Future Trends

Table 9: Global Non-injectable Insulin Market, Major Trends

Table 10: Global Non-injectable Insulin Market, Major End Users

Table 11: Global Non-injectable Insulin Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Non-injectable Insulin Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Non-injectable Insulin Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Non-injectable Insulin Market - TAM, US$ Billion, 2025

Table 15: Global Non-injectable Insulin Market, Segmentation By Insulin Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Non-injectable Insulin Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Non-injectable Insulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Non-injectable Insulin Market, Sub-Segmentation Of Oral Insulin, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Non-injectable Insulin Market, Sub-Segmentation Of Inhaled Insulin, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Non-injectable Insulin Market, Sub-Segmentation Of Nasal Insulin, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Non-injectable Insulin Market, Sub-Segmentation Of Buccal Or Sublingual Insulin, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Non-injectable Insulin Market, Sub-Segmentation Of Transdermal Insulin, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Non-injectable Insulin Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Global Non-injectable Insulin Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Asia-Pacific, Non-injectable Insulin Market, Segmentation By Insulin Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, Non-injectable Insulin Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: Asia-Pacific, Non-injectable Insulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: China, Non-injectable Insulin Market, Segmentation By Insulin Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, Non-injectable Insulin Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: China, Non-injectable Insulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: India, Non-injectable Insulin Market, Segmentation By Insulin Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, Non-injectable Insulin Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: India, Non-injectable Insulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Japan, Non-injectable Insulin Market, Segmentation By Insulin Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, Non-injectable Insulin Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Japan, Non-injectable Insulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Australia, Non-injectable Insulin Market, Segmentation By Insulin Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, Non-injectable Insulin Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Australia, Non-injectable Insulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Indonesia, Non-injectable Insulin Market, Segmentation By Insulin Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, Non-injectable Insulin Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: Indonesia, Non-injectable Insulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: South Korea, Non-injectable Insulin Market, Segmentation By Insulin Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, Non-injectable Insulin Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: South Korea, Non-injectable Insulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Taiwan, Non-injectable Insulin Market, Segmentation By Insulin Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, Non-injectable Insulin Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: Taiwan, Non-injectable Insulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: South East Asia, Non-injectable Insulin Market, Segmentation By Insulin Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, Non-injectable Insulin Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: South East Asia, Non-injectable Insulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Western Europe, Non-injectable Insulin Market, Segmentation By Insulin Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, Non-injectable Insulin Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: Western Europe, Non-injectable Insulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: UK, Non-injectable Insulin Market, Segmentation By Insulin Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, Non-injectable Insulin Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: UK, Non-injectable Insulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: Germany, Non-injectable Insulin Market, Segmentation By Insulin Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, Non-injectable Insulin Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: Germany, Non-injectable Insulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: France, Non-injectable Insulin Market, Segmentation By Insulin Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, Non-injectable Insulin Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: France, Non-injectable Insulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Italy, Non-injectable Insulin Market, Segmentation By Insulin Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, Non-injectable Insulin Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Italy, Non-injectable Insulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Spain, Non-injectable Insulin Market, Segmentation By Insulin Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, Non-injectable Insulin Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Spain, Non-injectable Insulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Eastern Europe, Non-injectable Insulin Market, Segmentation By Insulin Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, Non-injectable Insulin Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Eastern Europe, Non-injectable Insulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Russia, Non-injectable Insulin Market, Segmentation By Insulin Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, Non-injectable Insulin Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: Russia, Non-injectable Insulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: North America, Non-injectable Insulin Market, Segmentation By Insulin Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, Non-injectable Insulin Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: North America, Non-injectable Insulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: USA, Non-injectable Insulin Market, Segmentation By Insulin Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, Non-injectable Insulin Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: USA, Non-injectable Insulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: Canada, Non-injectable Insulin Market, Segmentation By Insulin Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, Non-injectable Insulin Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: Canada, Non-injectable Insulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: South America, Non-injectable Insulin Market, Segmentation By Insulin Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, Non-injectable Insulin Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: South America, Non-injectable Insulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Brazil, Non-injectable Insulin Market, Segmentation By Insulin Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, Non-injectable Insulin Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Brazil, Non-injectable Insulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Middle East, Non-injectable Insulin Market, Segmentation By Insulin Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, Non-injectable Insulin Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Middle East, Non-injectable Insulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Africa, Non-injectable Insulin Market, Segmentation By Insulin Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, Non-injectable Insulin Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Africa, Non-injectable Insulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 97: Global Non-injectable Insulin Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 98: Global Non-injectable Insulin Market - Company Scoring Matrix

Table 99: Novo Nordisk A/S Financial Performance

Table 100: Eli Lilly and Company Financial Performance

Table 101: Sanofi S.A. Financial Performance

Table 102: Pfizer Inc. Financial Performance

Table 103: Novartis AG Financial Performance

Table 104: Global Non-injectable Insulin Market, Competitive Benchmarking (In USD Billions)

Table 105: Global Non-injectable Insulin Market, Competitive Dashboard

Table 106: Global Non-injectable Insulin Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 107: Global, Non-injectable Insulin Market Size Gain ($ Billion), Segmentation By Insulin Type, 2025 – 2030

Table 108: Global, Non-injectable Insulin Market Size Gain ($ Billion), Segmentation By Product, 2025 – 2030

Table 109: Global, Non-injectable Insulin Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

List Of Figures

Figure 1: Global Non-injectable Insulin Market, Overview Of Key Products - Product Examples

Figure 2: Global Non-injectable Insulin Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Non-injectable Insulin Market, Supply Chain Analysis

Figure 4: Global Non-injectable Insulin Market, Major Raw Material Providers

Figure 5: Global Non-injectable Insulin Market, Major Resource Providers

Figure 6: Global Non-injectable Insulin Market, Major Manufacturers (Suppliers)

Figure 7: Global Non-injectable Insulin Market, Major Distributors And Channel Partners

Figure 8: Global Non-injectable Insulin Market, Key Technologies & Future Trends

Figure 9: Global Non-injectable Insulin Market, Major Trends

Figure 10: Global Non-injectable Insulin Market, Major End Users

Figure 11: Global Non-injectable Insulin Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Non-injectable Insulin Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Non-injectable Insulin Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Non-injectable Insulin Market - TAM, US$ Billion, 2025

Figure 15: Global Non-injectable Insulin Market, Segmentation By Insulin Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Non-injectable Insulin Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Non-injectable Insulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Non-injectable Insulin Market, Sub-Segmentation Of Oral Insulin, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Non-injectable Insulin Market, Sub-Segmentation Of Inhaled Insulin, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Non-injectable Insulin Market, Sub-Segmentation Of Nasal Insulin, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Non-injectable Insulin Market, Sub-Segmentation Of Buccal Or Sublingual Insulin, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Non-injectable Insulin Market, Sub-Segmentation Of Transdermal Insulin, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Non-injectable Insulin Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Global Non-injectable Insulin Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Asia-Pacific, Non-injectable Insulin Market, Segmentation By Insulin Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, Non-injectable Insulin Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: Asia-Pacific, Non-injectable Insulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: China, Non-injectable Insulin Market, Segmentation By Insulin Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, Non-injectable Insulin Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: China, Non-injectable Insulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: India, Non-injectable Insulin Market, Segmentation By Insulin Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, Non-injectable Insulin Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: India, Non-injectable Insulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Japan, Non-injectable Insulin Market, Segmentation By Insulin Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, Non-injectable Insulin Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Japan, Non-injectable Insulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Australia, Non-injectable Insulin Market, Segmentation By Insulin Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, Non-injectable Insulin Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Australia, Non-injectable Insulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Indonesia, Non-injectable Insulin Market, Segmentation By Insulin Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, Non-injectable Insulin Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: Indonesia, Non-injectable Insulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: South Korea, Non-injectable Insulin Market, Segmentation By Insulin Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, Non-injectable Insulin Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: South Korea, Non-injectable Insulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Taiwan, Non-injectable Insulin Market, Segmentation By Insulin Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, Non-injectable Insulin Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: Taiwan, Non-injectable Insulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: South East Asia, Non-injectable Insulin Market, Segmentation By Insulin Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, Non-injectable Insulin Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: South East Asia, Non-injectable Insulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Western Europe, Non-injectable Insulin Market, Segmentation By Insulin Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, Non-injectable Insulin Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: Western Europe, Non-injectable Insulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: UK, Non-injectable Insulin Market, Segmentation By Insulin Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, Non-injectable Insulin Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: UK, Non-injectable Insulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: Germany, Non-injectable Insulin Market, Segmentation By Insulin Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, Non-injectable Insulin Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: Germany, Non-injectable Insulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: France, Non-injectable Insulin Market, Segmentation By Insulin Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, Non-injectable Insulin Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: France, Non-injectable Insulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Italy, Non-injectable Insulin Market, Segmentation By Insulin Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, Non-injectable Insulin Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Italy, Non-injectable Insulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Spain, Non-injectable Insulin Market, Segmentation By Insulin Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, Non-injectable Insulin Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Spain, Non-injectable Insulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Eastern Europe, Non-injectable Insulin Market, Segmentation By Insulin Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, Non-injectable Insulin Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Eastern Europe, Non-injectable Insulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Russia, Non-injectable Insulin Market, Segmentation By Insulin Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, Non-injectable Insulin Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: Russia, Non-injectable Insulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: North America, Non-injectable Insulin Market, Segmentation By Insulin Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, Non-injectable Insulin Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: North America, Non-injectable Insulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: USA, Non-injectable Insulin Market, Segmentation By Insulin Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, Non-injectable Insulin Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: USA, Non-injectable Insulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: Canada, Non-injectable Insulin Market, Segmentation By Insulin Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, Non-injectable Insulin Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: Canada, Non-injectable Insulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: South America, Non-injectable Insulin Market, Segmentation By Insulin Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, Non-injectable Insulin Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: South America, Non-injectable Insulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Brazil, Non-injectable Insulin Market, Segmentation By Insulin Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, Non-injectable Insulin Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Brazil, Non-injectable Insulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Middle East, Non-injectable Insulin Market, Segmentation By Insulin Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, Non-injectable Insulin Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Middle East, Non-injectable Insulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Africa, Non-injectable Insulin Market, Segmentation By Insulin Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, Non-injectable Insulin Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Africa, Non-injectable Insulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 97: Global Non-injectable Insulin Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 98: Global Non-injectable Insulin Market - Company Scoring Matrix

Figure 99: Novo Nordisk A/S Financial Performance

Figure 100: Eli Lilly and Company Financial Performance

Figure 101: Sanofi S.A. Financial Performance

Figure 102: Pfizer Inc. Financial Performance

Figure 103: Novartis AG Financial Performance

Figure 104: Global Non-injectable Insulin Market, Competitive Benchmarking (In USD Billions)

Figure 105: Global Non-injectable Insulin Market, Competitive Dashboard

Figure 106: Global Non-injectable Insulin Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 107: Global, Non-injectable Insulin Market Size Gain ($ Billion), Segmentation By Insulin Type, 2025 – 2030

Figure 108: Global, Non-injectable Insulin Market Size Gain ($ Billion), Segmentation By Product, 2025 – 2030

Figure 109: Global, Non-injectable Insulin Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

Global Oncology Precision Medicine Market Landscape: Trends and Market Share to 2029

Competitive and Market Trend Analysis of Oral Antidiabetic Drugs Industry Through 2029

Key Market Drivers, Trends, and Forecast for the Global Orally Disintegrating Tablet Industry

Global Insights: Over-The-Counter (OTC) Artificial Tears Market Expected to Surpass $6.19 Billion by 2029

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

A 2025 analysis tracking API pricing, competitive landscape, and growth strategies in the losartan potassium active pharmaceutical ingredient market.

Insulin Pens, Syringes, Pumps And Injectors Market - By Type (Pens, Injectors And Pumps, Syringes), By End Users (Hospitals, Homecare), By Pens (Reusable, Disposable), By Pumps (Tubed Pumps, Tubeless Pumps), And By Regio...

Tissue Sectioning Market Report 2026 - Global Outlook – By Product (Accessories And Consumables, Instruments, Services), By Technology (Automatic, Manual, Semi-Automatic), By Application (Diagnosis, Research), By End-Use...

Ready To Drink (RTD) Alcoholic Beverages Market Report 2026 - Global Outlook – By Type (Alcopop, Cocktail Pre-Mixes, Bottled Cocktails), By Flavor (Regular, Flavored), By Packaging Type (Bottle, Can, Other Packaging Type...

Technical Insulation Market Report 2026 - Global Outlook – By Product (Flexible Foam, Rigid Foam, Man-made Mineral Fiber ), By Application (Heating & Plumbing, HVAC, Refrigeration, Industrial Processes), By End User (Ind...

Automation Testing Market Report 2026 - Global Outlook – By Component (Testing Type, Services), By Type (Functional Testing, Non-Functional Testing), By Service (Advisory And Consulting Services, Planning And Development...

Facial Steamer Market Report 2026 - Global Outlook – By Type (Face Steam Inhaler, Face Steam Aromatherapy, Facial Steamer, Face Steam Vaporizer, Facial Sauna), By Category (Tabletop, Portable), By Application (Salons And...

Frequently Asked Questions

How big is the Non-injectable Insulin Market?

The Non-injectable Insulin market was valued at $2.14 billion in 2025, increased to $2.35 billion in 2026, and is projected to reach $3.41 billion by 2030.

What is the Non-injectable Insulin market growth?

The global Non-injectable Insulin market is expected to grow at a CAGR of 9.8% from 2026 to 2035 to reach $3.41 billion by 2035.

Who are the key players in Non-injectable Insulin market?

Some Key Players in the Non-injectable Insulin market Include, Novo Nordisk A/S, Eli Lilly and Company, Sanofi S.A., Pfizer Inc., Novartis AG, Merck & Co. Inc., AstraZeneca, Takeda Pharmaceutical, Abbott Laboratories, MannKind Corporation, Biocon Limi

Major trend in this market includes: Innovative Advancements In Non-Injectable Insulin Delivery. For further insights on this market. request a sample here

North America was the largest region in the non-injectable insulin market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the non-injectable insulin market report are Asia-Pac

Book your 30 minutes free consultation with our research experts

Contact Us